Stuvia.com /f- /fThe /fMarketplace /fto /fBuy /fand /fSell /fyour /fStudy
Material
TestBank:
/f
Advanced PharmacologyforPrescribers 1stEdition Luu KayingoLatestEdi
/f /f j /f j j /f
tion,2024
/f /f
, Stuvia.com /f- /fThe /fMarketplace /fto /fBuy /fand /fSell /fyour /fStudy
Material
Table ofContents j
Chapterj 1: An Introductionj to Evidence-Based Clinicalj PracticeGuidelines................................................. 3
/f /f /f /f /f /f /f /f
Chapterj2:Pharmacokinetics /Chapter3:Pharmacodynamics ........................................................................ 13
/f /f /f
Chapter4: Pharmacogeneticsj and Pharmacogenomics ................................................................................ 25
/f /f /f
Chapter5:Pharmacology AcrossthejLife Span .............................................................................................. 30
/f /f /f /f /f
Chapter 6: Drug-Therapy Prescribingjin Special Populations ....................................................................... 36
/f /f /f /f /f
Chapter7:DrugDevelopmentj and Approval ................................................................................................. 45
/f /f /f /f /f
Chapter 8-Chapter 10: Foundations of Prescription WritingjChapter 9: ResponsibleControlled-
/f /f /f /f / f /f /f /f
/ Substance Prescribing Chapter 10:Antibiotic Stewardship ...................................................................... 51
f /f /f /f /f
Chapter11:Applied Calculationsjfor Prescribing .......................................................................................... 58
/f /f /f /f
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
/f /f /f /f /f /f /f /f /f
Focused PrescribingjChapter 13: Pharmacotherapyfor Ear, Nose,Mouth,andThroat Conditions/Chapter 14:
/f /f /f /f /f /f /f /f /f
PharmacotherapyforEyejConditions ........................................................................................................... 67
/f /f
Chapter 15: Pharmacotherapy for Skin Conditions ....................................................................................... 74
/f /f /f /f /f
Chapter 16: Pharmacotherapy for Neurologic Conditions ............................................................................ 81
/f /f /f /f /f
Chapterj 17:Pharmacotherapyfor Cardiovascular Conditions ...................................................................... 94
/f /f /f /f
Chapterj 18: Pharmacotherapyforj Respiratory Conditions......................................................................... 106
/f /f /f /f
Chapter 19: PharmacotherapyforGastrointestinal Conditionsand Conditions RequiringNutritional Support
/f /f /f /f /f /f
................................................................................................................................................................... 117
Chapterj 20:PharmacotherapyforjGenitourinary Conditions....................................................................... 128
/f /f /f /f
Chapter21:Pharmacotherapyfor Renal, Acid–Base, Fluid,and ElectrolytejDisorders ................................. 133
/f /f /f /f /f /f /f
Chapter 22:Pharmacotherapyfor Musculoskeletaland Rheumatologic Conditions .................................... 146
/f /f /f /f /f /f
Chapter23:Therapeutic Applicationsjof Immunology and Vaccines ........................................................... 158
/f /f /f /f /f /f
Chapter 24:Pharmacotherapyfor Endocrine Disorders................................................................................ 163
/f /f /f /f /f
Chapterj25:Pharmacotherapyfor Hematologic Disorders ........................................................................... 174
/f /f /f /f
Chapterj26:Hematology/Oncologyand Supportive Careforj the Nononcologist ........................................ 190
/f /f /f /f /f
Chapter 27:Pharmacotherapy Relatedj to Women’s Health Conditions ...................................................... 196
/f /f /f /f /f /f /f
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ............................................................ 211
/f /f /f /f /f /f /f
Chapter 29: Pharmacotherapy Relatedj to Transgender Care....................................................................... 217
/f /f /f /f /f /f
Chapter30:AntimicrobialPharmacotherapy ............................................................................................... 224
/f /f /f
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................... 235
/f /f /f
Chapter32:PsychopharmacologyandIntegrative Health:Combined TreatmentofPsychiatricjandNeurocogn
/f /f /f /f /f /f /f /f
itiveConditions.......................................................................................................................................... 247
/f /f
Chapter 33:Pharmacotherapyfor Pain Management .................................................................................. 257
/f /f /f /f
Chapterj34: Substance Use Disorderj III: Health Promotion and Maintenance ............................................. 267
/f /f /f /f /f /f /f /f
Chapterj35:Over-the-CounterjMedications................................................................................................. 283
Chapterj36: Pharmacotherapy forjObesity .................................................................................................. 291
/f /f
, Stuvia.com /f- /fThe /fMarketplace /fto /fBuy /fand /fSell /fyour /fStudy
Material
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
/f /f /f / f /f /f /f /f
MULTIPLECHOICE /f
• What is the primary purpose of the nursing assessment?
/f /f /f /f /f /f /f /f
A. Identifyingj underlyingj pathologic /f /f / f conditions
B. Assisting thej physician in identifying medical conditions /f /f / f /f /f /f
C. Determining the patients mental status /f /f /f /f
D. Exploring patientj responses to health problems /f /f /f / f / f
ANS:jD
A nursingassessment is done to identify thejpatients response to health proble
/f /f /f /f /f /f /f /f /f /f
ms. Duringthe nursingjassessment phase, a comprehensiveinformation
/f /f /f /f /f /f
base i s developed through ajphysical examination, nursingjhistory,
/ f /f /f /f /f /f /f /f
medication
/f histo ry, and professionaljobservation. /f /f /f / f
Identifyingunderlyingpathologic condition
/f s and assistingjthe physician /f / f /f /f /f
in identifyingmedical conditions is notjpart of thej nursingjprocess.
/f /f /f /f /f /f /f / f
Determiningjthe patients mental status is one partj of the nurs ing
/f /f / f /f / f / f /f /f /f /f /f
assessment, but it is notjthe primary purpose.
/f /f / f / f / f /f /f
DIF: Cognitive Level: Comprehension
/f /f /f
REF:dm 36 OBJ:1 |3 TOP: NursingjPro
/f /f /f /f /f /f /f /f /f
cess Step: Assessment
/f /f /f
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
/f /f /f /f /f /f /f /f
• Whatjis the basis of the NANDAI taxonomy? /f /f /f /f /f /f
A. Functional health patterns /f /f
B. Human response patterns /f / f
C. Basic human needs /f /f
D. Pathophysiologic needs /f
ANS:jB
The NANDA I taxonomy identifiesj human response patterns. Functional
/f /f /f /f /f /f /f /f
components of health patterns are limited to activity, fluidvolume,
/f /f /f /f /f /f /f /f /f
nutrition, self care, and sensory perception. Basic human needs comprise
/f /f /f /f /f /f /f /f /f /f
less than mer ely health patterns. Pathophysiologic needs are notpart of
/f /f /f /f /f /f /f /f /f / f /f
the scopejof NAN DAI.
/f /f /f /f
, Stuvia.com /f- /fThe /fMarketplace /fto /fBuy /fand /fSell /fyour /fStudy
Material
DIF: Cognitive Level: Knowledge REF:
/f /f /f /f
pp. 37-38 OBJ: 5 TOP:
/f /f /f /f
NursingjProcess Step: Diagnosis /f /f
MSC: NCLEX Client Needs Category: Physiological Integrity
/f /f /f /f /f /f
• Which task is included in the assessment step of the nursing process?
/f /f /f /f /f /f /f /f /f /f /f
A. Establishing patient goals/outcomes /f / f
B. Implementingj the nursingj care plan (NCP) /f /f /f /f / f
C. Measuringj goal/outcome achievement /f /f
D. Collectingjand communicatingj data / f /f
ANS: D /f
Data are collected and communicated in the assessment phase of the
/f /f /f /f /f /f /f /f /f /f
nursingp rocess. Establishingjgoals is thejfunction of planning.
/f /f /f /f /f /f /f
Implementingthe NCP is the function of implementation. /f /f /f /f /f /f
Measuringjoutcom e achievement is the function of evaluation.
/f / f /f /f /f /f /f /f
DIF: Cognitive Level: Comprehension
/f /f /f
REF:dm 36 OBJ:2 |3 TOP:NursingPro
/f /f /f /f /f /f /f /f /f /f
cess Step: Assessment
/f /f /f
MSC: NCLEXj Clientj Needs Category: Health Promotion and Maintenance
/f /f /f /f /f /f /f /f
• Which statement regardingj nursing diagnoses is accurate?
/f /f /f /f /f / f
a. Nursingdiagnoses remain the same for as longjas the disease is present. /f /f /f /f /f /f /f /f /f / f
b. Nursing diagnoses are written to identify disease states. /f /f /f /f /f /f /f
c. Nursing diagnoses describe patient problems that nurses treat. /f /f /f /f /f /f / f
d. Nursing diagnoses identify causes related to illness. /f /f /f /f /f /f
ANS:jC
Diagnostic statements identify problemsja nurse is independently able to treat
/f /f /f /f /f /f /f /f /f
within the scope of professional practice. Nursingjdiagnoses vary with the
/f /f /f /f /f /f /f /f /f /f
ch angingjcondition of the patient. The responsepatterns arejunique to the
/f /f /f /f /f /f /f /f /f /f
patien
/f t and are notjdisease specific. Nursingdiagnoses describethe
/ f /f /f /f /f /f /f
patients humanjr esponse pattern.
/f /f /f /f
DIF: Cognitive Level: Comprehension
/f /f /f
Material
TestBank:
/f
Advanced PharmacologyforPrescribers 1stEdition Luu KayingoLatestEdi
/f /f j /f j j /f
tion,2024
/f /f
, Stuvia.com /f- /fThe /fMarketplace /fto /fBuy /fand /fSell /fyour /fStudy
Material
Table ofContents j
Chapterj 1: An Introductionj to Evidence-Based Clinicalj PracticeGuidelines................................................. 3
/f /f /f /f /f /f /f /f
Chapterj2:Pharmacokinetics /Chapter3:Pharmacodynamics ........................................................................ 13
/f /f /f
Chapter4: Pharmacogeneticsj and Pharmacogenomics ................................................................................ 25
/f /f /f
Chapter5:Pharmacology AcrossthejLife Span .............................................................................................. 30
/f /f /f /f /f
Chapter 6: Drug-Therapy Prescribingjin Special Populations ....................................................................... 36
/f /f /f /f /f
Chapter7:DrugDevelopmentj and Approval ................................................................................................. 45
/f /f /f /f /f
Chapter 8-Chapter 10: Foundations of Prescription WritingjChapter 9: ResponsibleControlled-
/f /f /f /f / f /f /f /f
/ Substance Prescribing Chapter 10:Antibiotic Stewardship ...................................................................... 51
f /f /f /f /f
Chapter11:Applied Calculationsjfor Prescribing .......................................................................................... 58
/f /f /f /f
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
/f /f /f /f /f /f /f /f /f
Focused PrescribingjChapter 13: Pharmacotherapyfor Ear, Nose,Mouth,andThroat Conditions/Chapter 14:
/f /f /f /f /f /f /f /f /f
PharmacotherapyforEyejConditions ........................................................................................................... 67
/f /f
Chapter 15: Pharmacotherapy for Skin Conditions ....................................................................................... 74
/f /f /f /f /f
Chapter 16: Pharmacotherapy for Neurologic Conditions ............................................................................ 81
/f /f /f /f /f
Chapterj 17:Pharmacotherapyfor Cardiovascular Conditions ...................................................................... 94
/f /f /f /f
Chapterj 18: Pharmacotherapyforj Respiratory Conditions......................................................................... 106
/f /f /f /f
Chapter 19: PharmacotherapyforGastrointestinal Conditionsand Conditions RequiringNutritional Support
/f /f /f /f /f /f
................................................................................................................................................................... 117
Chapterj 20:PharmacotherapyforjGenitourinary Conditions....................................................................... 128
/f /f /f /f
Chapter21:Pharmacotherapyfor Renal, Acid–Base, Fluid,and ElectrolytejDisorders ................................. 133
/f /f /f /f /f /f /f
Chapter 22:Pharmacotherapyfor Musculoskeletaland Rheumatologic Conditions .................................... 146
/f /f /f /f /f /f
Chapter23:Therapeutic Applicationsjof Immunology and Vaccines ........................................................... 158
/f /f /f /f /f /f
Chapter 24:Pharmacotherapyfor Endocrine Disorders................................................................................ 163
/f /f /f /f /f
Chapterj25:Pharmacotherapyfor Hematologic Disorders ........................................................................... 174
/f /f /f /f
Chapterj26:Hematology/Oncologyand Supportive Careforj the Nononcologist ........................................ 190
/f /f /f /f /f
Chapter 27:Pharmacotherapy Relatedj to Women’s Health Conditions ...................................................... 196
/f /f /f /f /f /f /f
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ............................................................ 211
/f /f /f /f /f /f /f
Chapter 29: Pharmacotherapy Relatedj to Transgender Care....................................................................... 217
/f /f /f /f /f /f
Chapter30:AntimicrobialPharmacotherapy ............................................................................................... 224
/f /f /f
Chapter 31: Antiretroviral Pharmacotherapy ............................................................................................... 235
/f /f /f
Chapter32:PsychopharmacologyandIntegrative Health:Combined TreatmentofPsychiatricjandNeurocogn
/f /f /f /f /f /f /f /f
itiveConditions.......................................................................................................................................... 247
/f /f
Chapter 33:Pharmacotherapyfor Pain Management .................................................................................. 257
/f /f /f /f
Chapterj34: Substance Use Disorderj III: Health Promotion and Maintenance ............................................. 267
/f /f /f /f /f /f /f /f
Chapterj35:Over-the-CounterjMedications................................................................................................. 283
Chapterj36: Pharmacotherapy forjObesity .................................................................................................. 291
/f /f
, Stuvia.com /f- /fThe /fMarketplace /fto /fBuy /fand /fSell /fyour /fStudy
Material
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
/f /f /f / f /f /f /f /f
MULTIPLECHOICE /f
• What is the primary purpose of the nursing assessment?
/f /f /f /f /f /f /f /f
A. Identifyingj underlyingj pathologic /f /f / f conditions
B. Assisting thej physician in identifying medical conditions /f /f / f /f /f /f
C. Determining the patients mental status /f /f /f /f
D. Exploring patientj responses to health problems /f /f /f / f / f
ANS:jD
A nursingassessment is done to identify thejpatients response to health proble
/f /f /f /f /f /f /f /f /f /f
ms. Duringthe nursingjassessment phase, a comprehensiveinformation
/f /f /f /f /f /f
base i s developed through ajphysical examination, nursingjhistory,
/ f /f /f /f /f /f /f /f
medication
/f histo ry, and professionaljobservation. /f /f /f / f
Identifyingunderlyingpathologic condition
/f s and assistingjthe physician /f / f /f /f /f
in identifyingmedical conditions is notjpart of thej nursingjprocess.
/f /f /f /f /f /f /f / f
Determiningjthe patients mental status is one partj of the nurs ing
/f /f / f /f / f / f /f /f /f /f /f
assessment, but it is notjthe primary purpose.
/f /f / f / f / f /f /f
DIF: Cognitive Level: Comprehension
/f /f /f
REF:dm 36 OBJ:1 |3 TOP: NursingjPro
/f /f /f /f /f /f /f /f /f
cess Step: Assessment
/f /f /f
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
/f /f /f /f /f /f /f /f
• Whatjis the basis of the NANDAI taxonomy? /f /f /f /f /f /f
A. Functional health patterns /f /f
B. Human response patterns /f / f
C. Basic human needs /f /f
D. Pathophysiologic needs /f
ANS:jB
The NANDA I taxonomy identifiesj human response patterns. Functional
/f /f /f /f /f /f /f /f
components of health patterns are limited to activity, fluidvolume,
/f /f /f /f /f /f /f /f /f
nutrition, self care, and sensory perception. Basic human needs comprise
/f /f /f /f /f /f /f /f /f /f
less than mer ely health patterns. Pathophysiologic needs are notpart of
/f /f /f /f /f /f /f /f /f / f /f
the scopejof NAN DAI.
/f /f /f /f
, Stuvia.com /f- /fThe /fMarketplace /fto /fBuy /fand /fSell /fyour /fStudy
Material
DIF: Cognitive Level: Knowledge REF:
/f /f /f /f
pp. 37-38 OBJ: 5 TOP:
/f /f /f /f
NursingjProcess Step: Diagnosis /f /f
MSC: NCLEX Client Needs Category: Physiological Integrity
/f /f /f /f /f /f
• Which task is included in the assessment step of the nursing process?
/f /f /f /f /f /f /f /f /f /f /f
A. Establishing patient goals/outcomes /f / f
B. Implementingj the nursingj care plan (NCP) /f /f /f /f / f
C. Measuringj goal/outcome achievement /f /f
D. Collectingjand communicatingj data / f /f
ANS: D /f
Data are collected and communicated in the assessment phase of the
/f /f /f /f /f /f /f /f /f /f
nursingp rocess. Establishingjgoals is thejfunction of planning.
/f /f /f /f /f /f /f
Implementingthe NCP is the function of implementation. /f /f /f /f /f /f
Measuringjoutcom e achievement is the function of evaluation.
/f / f /f /f /f /f /f /f
DIF: Cognitive Level: Comprehension
/f /f /f
REF:dm 36 OBJ:2 |3 TOP:NursingPro
/f /f /f /f /f /f /f /f /f /f
cess Step: Assessment
/f /f /f
MSC: NCLEXj Clientj Needs Category: Health Promotion and Maintenance
/f /f /f /f /f /f /f /f
• Which statement regardingj nursing diagnoses is accurate?
/f /f /f /f /f / f
a. Nursingdiagnoses remain the same for as longjas the disease is present. /f /f /f /f /f /f /f /f /f / f
b. Nursing diagnoses are written to identify disease states. /f /f /f /f /f /f /f
c. Nursing diagnoses describe patient problems that nurses treat. /f /f /f /f /f /f / f
d. Nursing diagnoses identify causes related to illness. /f /f /f /f /f /f
ANS:jC
Diagnostic statements identify problemsja nurse is independently able to treat
/f /f /f /f /f /f /f /f /f
within the scope of professional practice. Nursingjdiagnoses vary with the
/f /f /f /f /f /f /f /f /f /f
ch angingjcondition of the patient. The responsepatterns arejunique to the
/f /f /f /f /f /f /f /f /f /f
patien
/f t and are notjdisease specific. Nursingdiagnoses describethe
/ f /f /f /f /f /f /f
patients humanjr esponse pattern.
/f /f /f /f
DIF: Cognitive Level: Comprehension
/f /f /f